Sanofi has entered into an agreement to acquire Vigil Neuroscience Inc., a publicly traded clinical-stage biotechnology ...

The BioMed X Institute has launched a new global call for research proposals in collaboration with Boehringer Ingelheim.

Bora Biologics, a contract development and manufacturing organization (CDMO) specializing in biologics manufacturing, is ...

The new bioconjugation site completes the CDMO’s capabilities across payload, linker, and Mab, with onboarding set to start ...

The U.S. Food and Drug Administration (FDA) has granted an expanded interchangeable designation for Celltrion’s YUFLYMA.

Inhaled therapeutics is an area of the pharmaceutical industry that is in high demand and is set for continued growth in the ...

Oral solid dosage forms such as tablets and capsules remain the most widely used method for delivering drug products to ...

The nasal route offers a number of benefits over some of the traditional routes of administration for biologics.

Pharmaceutical granulation techniques continue to be developed and improved with modified / novel technologies and processing ...

Traditionally, spray drying has been utilized as a useful technology for enhancing the delivery of small molecules via the ...

There have been a growing number of drug products approved that look to target the brain following intranasal delivery.

Interest in developing nasal dosage forms has increased significantly in the last two years, driven by a number of recent ...